OHR Pharmaceutical Company Profile (NASDAQ:OHRP)

About OHR Pharmaceutical

OHR Pharmaceutical logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OHRP
  • CUSIP:
Key Metrics:
  • Previous Close: $1.05
  • 50 Day Moving Average: $1.42
  • 200 Day Moving Average: $2.37
  • 52-Week Range: $0.95 - $4.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.82
  • P/E Growth: -0.01
  • Market Cap: $37.76M
  • Outstanding Shares: 35,961,000
  • Beta: 0.92
Profitability:
  • Return on Equity: -80.25%
  • Return on Assets: -70.12%
Debt:
  • Current Ratio: 2.96%
  • Quick Ratio: 2.96%
Additional Links:
Companies Related to OHR Pharmaceutical:

Analyst Ratings

Consensus Ratings for OHR Pharmaceutical (NASDAQ:OHRP) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $17.67 (1,582.54% upside)

Analysts' Ratings History for OHR Pharmaceutical (NASDAQ:OHRP)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017HC WainwrightSet Price TargetBuy$10.00View Rating Details
10/4/2016Brean CapitalInitiated CoverageHoldView Rating Details
6/16/2016Roth CapitalReiterated RatingBuy$13.00View Rating Details
5/16/2016Chardan CapitalReiterated RatingHoldView Rating Details
3/2/2015Cowen and CompanyInitiated CoverageOutperform$25.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for OHR Pharmaceutical (NASDAQ:OHRP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017        
2/14/2017Q117($0.19)($0.21)ViewListenView Earnings Details
5/10/2016Q2($0.18)($0.17)ViewListenView Earnings Details
12/10/2015Q415($0.20)($0.13)ViewListenView Earnings Details
5/11/2015Q215($0.17)($0.12)ViewListenView Earnings Details
2/9/2015Q115($0.20)($0.18)ViewN/AView Earnings Details
12/22/2014($0.10)($0.12)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OHR Pharmaceutical (NASDAQ:OHRP)
Current Year EPS Consensus Estimate: $-1.05 EPS
Next Year EPS Consensus Estimate: $-1.28 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.23)($0.23)($0.23)
Q4 20161($0.26)($0.26)($0.26)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OHR Pharmaceutical (NASDAQ:OHRP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OHR Pharmaceutical (NASDAQ:OHRP)
Insider Ownership Percentage: 17.70%
Institutional Ownership Percentage: 9.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/20/2016Jason Scott SlakterCEOBuy8,786$2.85$25,040.10View SEC Filing  
6/20/2016Samuel BackenrothCFOBuy2,468$2.84$7,009.12View SEC Filing  
5/25/2016Jason Scott SlakterCEOBuy3,682$3.11$11,451.02View SEC Filing  
5/24/2016Jason Scott SlakterCEOBuy28,068$3.15$88,414.20View SEC Filing  
5/23/2016Samuel BackenrothCFOBuy2,500$3.17$7,925.00View SEC Filing  
4/11/2016Jason Scott SlakterCEOBuy6,250$3.35$20,937.50View SEC Filing  
3/7/2016Jason Scott SlakterCEOBuy6,250$3.63$22,687.50View SEC Filing  
2/22/2016Jason Scott SlakterCEOBuy6,250$3.11$19,437.50View SEC Filing  
1/19/2016Jason Scott SlakterCEOBuy6,250$3.62$22,625.00View SEC Filing  
12/7/2015Jason Scott SlakterCEOBuy3,000$4.07$12,210.00View SEC Filing  
11/3/2015Jason Scott SlakterCEOBuy13,350$3.00$40,050.00View SEC Filing  
2/6/2015Irach B TaraporewalaCEOBuy3,705$6.75$25,008.75View SEC Filing  
2/6/2015June Sherie AlmenoffDirectorBuy6,000$6.75$40,500.00View SEC Filing  
2/6/2015Samuel BackenrothCFOBuy1,500$6.75$10,125.00View SEC Filing  
9/3/2014June Sherie AlmenoffDirectorBuy2,200$8.08$17,776.00View SEC Filing  
7/2/2014Ira A GreensteinDirectorBuy1,000$8.40$8,400.00View SEC Filing  
6/26/2014June Sherie AlmenoffDirectorBuy3,200$8.34$26,688.00View SEC Filing  
6/25/2014Thomas M RiedhammerDirectorBuy6,900$7.39$50,991.00View SEC Filing  
4/9/2014Ira A GreensteinDirectorBuy2,500$10.20$25,500.00View SEC Filing  
4/8/2014June Sherie AlmenoffDirectorBuy5,500$10.25$56,375.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OHR Pharmaceutical (NASDAQ:OHRP)
DateHeadline
News IconOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Quarterly EPS At $-0.32 - Stock Observer (NASDAQ:OHRP)
www.thestockobserver.com - February 18 at 11:48 AM
News IconMarket Scout: Checking the Levels for Ohr Pharmaceutical Inc. (OHRP) - Baxter Review (NASDAQ:OHRP)
baxternewsreview.com - February 17 at 8:18 AM
investopedia.com logoOhr Reports 4Q Loss, Suspends Trial (OHRP) (NASDAQ:OHRP)
www.investopedia.com - February 16 at 6:34 PM
News IconAre Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Shares Headed Higher? - Rockville Register (NASDAQ:OHRP)
rockvilleregister.com - February 16 at 6:34 PM
News IconPulling Back The Curtain on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Analysts & Wall Street Chime In - Winfield Review (NASDAQ:OHRP)
winfieldreview.com - February 16 at 6:34 PM
us.rd.yahoo.com logoOhr Pharmaceutical Reports 4Q Loss, Suspends Trial (NASDAQ:OHRP)
us.rd.yahoo.com - February 16 at 6:34 PM
News IconPeeling Back The Layers on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Analysts & Street Weigh In - Winfield Review (NASDAQ:OHRP)
winfieldreview.com - February 15 at 3:28 AM
seekingalpha.com logoOhr Pharmaceutical's (OHRP) CEO Jason Slakter on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:OHRP)
seekingalpha.com - February 15 at 3:28 AM
4-traders.com logoOHR Pharmaceutical : reports 1Q loss (NASDAQ:OHRP)
www.4-traders.com - February 14 at 10:26 PM
finance.yahoo.com logoOhr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings (NASDAQ:OHRP)
finance.yahoo.com - February 14 at 10:26 PM
biz.yahoo.com logoOHR PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events (NASDAQ:OHRP)
biz.yahoo.com - February 14 at 10:26 PM
biz.yahoo.com logoQ1 2017 OHR Pharmaceutical Inc Earnings Release - Before Market Open (NASDAQ:OHRP)
biz.yahoo.com - February 14 at 10:26 PM
finance.yahoo.com logo7:08 am Ohr Pharma announces it remains in active ongoing discussions with potential pharma partners and, thus, has paused enrollment in the Phase 3 clinical trial of its lead candidate squalamine; also reports Q4 loss of ($0.21) vs ($0.19) (NASDAQ:OHRP)
finance.yahoo.com - February 14 at 10:26 PM
globenewswire.com logoOhr Pharmaceutical to Announce First Quarter 2017 Financial Results on February 14 - GlobeNewswire (press release) (NASDAQ:OHRP)
globenewswire.com - February 14 at 1:15 AM
News IconBroker Rating Review: NXP Semiconductors NV (NASDAQ:NXPI) Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - The Standard (NASDAQ:OHRP)
6milestandard.com - February 9 at 5:59 AM
News IconOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Daily Sentiment Score At 0.435 - Stock Observer (NASDAQ:OHRP)
www.thestockobserver.com - February 7 at 12:05 AM
News IconTechnical Indicator Review on Shares of Ohr Pharmaceutical Inc. (OHRP) - Sherwood Daily (NASDAQ:OHRP)
sherwooddaily.com - February 3 at 7:50 PM
News IconLooking at Moving Averages for Ohr Pharmaceutical Inc. (OHRP) - Sherwood Daily (NASDAQ:OHRP)
sherwooddaily.com - February 3 at 12:56 AM
News IconRange Watch on Technical Indicators for Ohr Pharmaceutical Inc. (OHRP) - Sherwood Daily (NASDAQ:OHRP)
sherwooddaily.com - January 27 at 12:03 AM
News IconAnalysts Peering Into Their Crystal Balls, What's the Sentiment on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 27 at 12:03 AM
News IconEarnings in Full Force, Analysts Take Aim at Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 27 at 12:03 AM
News IconSell-side Taking Aim at Shares of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Aiken Advocate (NASDAQ:OHRP)
aikenadvocate.com - January 25 at 12:50 AM
News IconChart Level Analysis on Shares of Ohr Pharmaceutical Inc. (OHRP) - Sherwood Daily (NASDAQ:OHRP)
sherwooddaily.com - January 25 at 12:50 AM
News IconPeeling Back The Layers on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Sell-Side Weighs In - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 25 at 12:50 AM
investornewswire.com logoSentiments And Ratings Alert: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Investor Newswire (NASDAQ:OHRP)
www.investornewswire.com - January 22 at 6:48 PM
News IconAnalysts Pull Back the Curtain on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Consensus Update - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 21 at 7:29 AM
News IconTechnical Update on Shares of Ohr Pharmaceutical Inc. (OHRP) - Sherwood Daily (NASDAQ:OHRP)
sherwooddaily.com - January 19 at 12:38 AM
News IconGearing Up For a Bull Run? Analysts Weigh in on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 19 at 12:38 AM
News IconTrading Roundup: Checking Technicals for Ohr Pharmaceutical Inc. (OHRP) - Sherwood Daily (NASDAQ:OHRP)
sherwooddaily.com - January 18 at 12:22 AM
News IconStock in the Limelight: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - January 18 at 12:22 AM
News IconEarnings Fever Sweeping In, What Are Analysts Expecting From Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)? - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 18 at 12:22 AM
News IconCan This Stock Gain Traction: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - January 16 at 7:31 PM
News IconOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Quarterly EPS Set At $-0.32 - Stock Observer (NASDAQ:OHRP)
www.thestockobserver.com - January 15 at 7:49 AM
News IconPrimed For An Earnings Beat? Sell-side Chimes in on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Stock - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 14 at 4:46 AM
News IconCheap Stock Alert & Update on Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - January 14 at 4:46 AM
News IconWill The Needle Move For Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:OHRP)
wsbeacon.com - January 14 at 4:46 AM
News IconAre There Any Catalysts to Propel This Stock Forward: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - January 13 at 8:16 AM
News IconNotable Stock For Under $5: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - January 10 at 8:45 AM
News IconOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Daily Sentiment Score At 0 - Stock Observer (NASDAQ:OHRP)
www.thestockobserver.com - January 9 at 7:42 PM
News IconOhr Pharmaceutical Inc OHRP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:OHRP)
www.bioportfolio.com - January 6 at 7:44 PM
finance.yahoo.com logoPost Earnings Coverage as Ohr Pharma Reported Annual Results; Announced Closure of Public Offering (NASDAQ:OHRP)
finance.yahoo.com - January 5 at 11:13 PM
News IconDaily Sentiment Score Of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) At -0.103 - Stock Observer (NASDAQ:OHRP)
www.thestockobserver.com - January 2 at 6:51 PM
News IconIs There a Catalyst Out There For Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - December 30 at 7:23 PM
finance.yahoo.com logoOHR PHARMACEUTICAL INC Financials (NASDAQ:OHRP)
finance.yahoo.com - December 30 at 7:23 PM
News IconCurious Investors Should Take a Look at This Small Cap Stock: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Prospect Journal (NASDAQ:OHRP)
prospectjournal.com - December 28 at 11:55 PM
News IconBearish Target Of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) At $10 - Stock Observer (NASDAQ:OHRP)
www.thestockobserver.com - December 28 at 11:55 PM
capitalcube.com logoOhr Pharmaceutical, Inc. :OHRP-US: Earnings Analysis: Q4, 2016 By the Numbers : December 27, 2016 (NASDAQ:OHRP)
www.capitalcube.com - December 27 at 6:51 PM
live-pr.com logoOhr Pharmaceutical Inc. (OHRP) - Financial and Strategic SWOT Analysis Review - New Market Research Report (NASDAQ:OHRP)
www.live-pr.com - December 27 at 9:56 AM
4-traders.com logoOHR PHARMACEUTICAL INC : Results of Operations and Financial Condition (form 8-K) (NASDAQ:OHRP)
www.4-traders.com - December 24 at 8:54 AM
baystreet.ca logoOHR Pharmaceutical (OHRP) Drops on Projected Loss (NASDAQ:OHRP)
www.baystreet.ca - December 23 at 7:09 PM

Social

What is OHR Pharmaceutical's stock symbol?

OHR Pharmaceutical trades on the NASDAQ under the ticker symbol "OHRP."

Where is OHR Pharmaceutical's stock going? Where will OHR Pharmaceutical's stock price be in 2017?

4 brokers have issued 12 month target prices for OHR Pharmaceutical's stock. Their predictions range from $10.00 to $30.00. On average, they anticipate OHR Pharmaceutical's stock price to reach $17.67 in the next twelve months.

When will OHR Pharmaceutical announce their earnings?

OHR Pharmaceutical is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

Who owns OHR Pharmaceutical stock?

OHR Pharmaceutical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include United Capital Financial Advisers LLC (0.24%) and Renaissance Technologies LLC (0.19%). Company insiders that own OHR Pharmaceutical stock include Jason Scott Slakter and Samuel Backenroth.

Who bought OHR Pharmaceutical stock? Who is buying OHR Pharmaceutical stock?

OHR Pharmaceutical's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought OHR Pharmaceutical stock in the last two years include Jason Scott Slakter and Samuel Backenroth.

How do I buy OHR Pharmaceutical stock?

Shares of OHR Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of OHR Pharmaceutical stock cost?

One share of OHR Pharmaceutical stock can currently be purchased for approximately $1.05.

OHR Pharmaceutical (NASDAQ:OHRP) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for OHR Pharmaceutical (NASDAQ:OHRP)

Earnings History Chart

Earnings by Quarter for OHR Pharmaceutical (NASDAQ:OHRP)

Dividend History Chart

Dividend Payments by Quarter for OHR Pharmaceutical (NASDAQ:OHRP)

Last Updated on 2/21/2017 by MarketBeat.com Staff